Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: Recommendations of the North America Society for Pediatric Gastroenterology and Nutrition

Journal of Pediatric Gastroenterology and Nutrition

Volumn 32, Issue SUPPL. 2, 2001, Pages

  Rudolph, C D ^a   Mazur, L J ^a   Liptak, G S ^a   Baker, R D ^a   Boyle, J T ^a   Colletti, R B ^a   Gerson, W T ^a   Werlin, S L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROKINETIC AGENT; PROTON PUMP INHIBITOR;

ABDOMINAL PAIN; ASTHMA; CHILD; DYSPHAGIA; ESOPHAGITIS; GASTROESOPHAGEAL REFLUX; HUMAN; LIFESTYLE; PATIENT POSITIONING; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; VOMITING; WEIGHT GAIN;

CHILD; CHILD NUTRITION PHYSIOLOGY; CHILD, PRESCHOOL; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL AGENTS; HUMANS; INFANT;

EID: 0034959961     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200100002-00001     Document Type: Review

References (336)

1. Continuous 24-hour esophageal pH monitoring in 285 asymptomatic infants 0-15 months old
2. Gastroesophageal reflux, as measured by 24-hour pH monitoring, in 509 healthy infants screened for risk of sudden infant death syndrome
3. 24-Hour esophageal two-level pH monitoring in healthy children and adolescents
4. Prevalence of symptoms of gastroesophageal reflux during childhood: A pediatric practice-based survey
5. Mechanisms of gastroesophageal reflux in children
6. Mechanisms responsible for gastroesophageal reflux in children
7. Prevalence of symptoms of gastroesophageal reflux during infancy. A pediatric practice-based survey
8. One-year follow-up of symptoms of gastroesophageal reflux during infancy
9. Sandifer syndrome: An unappreciated clinical entity
10. Gastroesophageal reflux in association with the Sandifer syndrome
11. Gastroesophageal reflux with protein-losing enteropathy and finger clubbing
12. Barrett's esophagus: New definitions and approaches in children
13. Three decision-making aids: Brainstorming, nominal group, and Delphi technique
14. Examination CTFotPH, the periodic health examination
15. Clinical and laboratory correlates of esophagitis in young children
16. Clinical and endoscopic predictors of histological esophagitis in infants
17. Gastroesophageal reflux - The acid test: Scintigraphy or the pH probe?
18. Diagnosis of gastroesophageal reflux in pediatrics
19. Value of tests for evaluation of gastroesophageal reflux in children
20. Detection of gastroesophageal reflux: Value of barium studies compared with 24-hr pH monitoring
21. Gastroesophageal reflux disease (GERD): An appraisal of different tests for diagnosis
22. Gastroesophageal reflux disease: Correlation of esophageal pH testing and radiographic findings
23. Statement of the North American Society for Pediatric Gastroenterology and Nutrition (NASPGN). Indications for pediatric esophageal pH monitoring
24. A new ambulatory system for extended esophageal pH monitoring
25. A standardized protocol for the methodology of esophageal pH monitoring and interpretation of the data for the diagnosis of gastroesophageal reflux
26. Lower esophageal pH monitoring - A useful clinical tool
27. Twenty-four-hour esophageal intraluminal pH probe testing: A comparative analysis
28. Reproducibility of 24-hour intraesophageal pH monitoring in pediatric patients
29. Reproducibility of 24-hour esophageal pH studies in infants
30. Reproducibility of continuous 24-hour esophageal pH monitoring in infants and children
31. Accuracy and reproducibility of 12-h esophageal pH monitoring
32. Reliability of short-term esophageal pH monitoring versus 24-hour study
33. Continuous monitoring of distal esophageal pH: A diagnostic test for gastroesophageal reflux in infants
34. Twenty-four-hour esophageal pH monitoring in gastroesophageal reflux
35. Ambulatory 24-h esophageal pH monitoring: Normal values, optimal thresholds, specificity, sensitivity, and reproducibility
36. 24-h pH monitoring for gastroesophageal reflux disease: Already standard but not yet gold?
37. Area under pH 4: Advantages of a new parameter in the interpretation of esophageal pH monitoring data in infants
38. Esophagitis in infants. Morphometric histological diagnosis and correlation with measures of gastroesophageal reflux
39. Value of the 24-hour intraesophageal pH monitoring in children
40. Are endoscopic changes predictive of histologic esophagitis in children?
41. Simultaneous prolonged recordings of proximal and distal intraesophageal pH in children with gastroesophageal reflux disease and respiratory symptoms
42. Reflux in infants with laryngomalacia: Results of 24-hour double-probe pH monitoring
43. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: Testing while on therapy identifies the need for more aggressive anti-reflux therapy
44. Behaviors associated with onset of gastroesophageal reflux episodes in infants. Prospective study using split-screen video and pH probe
45. Efficacy and safety of omeprazole for severe gastroesophageal reflux in children
46. Prevalence and treatment of silent gastroesophageal reflux in children with recurrent respiratory disorders
47. Gastroesophageal reflux and unexplained chronic respiratory disease in infants and children
48. Gastroesophageal reflux and bronchial asthma: Prevalence and effect of cisapride therapy
49. Surgical treatment of gastroesophageal reflux in children. Results of Nissen's fundoplication in 100 children
50. Endoscopic assessment of esophagitis: Clinical and functional correlates and further validation of the Los Angeles classification
51. Vertical lines in distal esophageal mucosa (VLEM): A true endoscopic manifestation of esophagitis in children?
52. Esophagitis: A frequent consequence of gastroesophageal reflux in infancy
53. Intraepithelial eosinophils: A new diagnostic criterion for reflux esophagitis
54. Primary eosinophilic esophagitis in children: Successful treatment with oral corticosteroids
55. Severity of esophageal eosinophilia predicts response to conventional gastroesophageal reflux therapy
56. Gastric emptying with gastro-oesophageal reflux
57. Increased incidence of delayed gastric emptying in children with gastroesophageal reflux. A prospective evaluation
58. Delayed gastric emptying in infants with gastroesophageal reflux
59. Pulmonary aspiration studied by radionuclide milk scanning and barium swallow roentgenography
60. How useful is gastroesophageal reflux scintigraphy in suspected childhood aspiration?
61. Gastroesophageal reflux in infants and children comparative accuracy of diagnostic methods
62. Comparison of evaluation of gastroesophageal reflux in infants using different feedings during intraesophageal pH monitoring
63. Diagnosis and treatment of gastroesophageal reflux in children and adolescents with severe asthma
64. Scintigraphy versus pH probe for quantification of pediatric gastroesophageal reflux: A study using concurrent multiplexed data and acid feedings
65. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease
66. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough
67. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: A prospective study
68. Quality of life in patients with heartburn but without esophagitis: Effects of treatment with omeprazole
69. On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis-a placebo-controlled randomized trial
70. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain
71. One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease
72. Heartburn risk factors, knowledge, and prevention strategies: A population-based survey of individuals with heartburn
73. Cow's milk protein allergy and gastro-oesophageal reflux
74. Gastroesophageal reflux and cow's milk allergy in infants: A prospective study
75. Challenge confirmation of late-onset reactions to extensively hydrolyzed formulas in infants with multiple food protein intolerance
76. Gastroesophageal reflux associated with cow's milk allergy in infants: Which diagnostic examinations are useful?
77. Clinical and pH-metric characteristics of gastro-oesophageal reflux secondary to cows' milk protein allergy
78. Influence of breast versus formula milk on physiological gastroesophageal reflux in healthy, newborn infants
79. Milk-thickening agents as a treatment for gastroesophageal reflux
80. Lack of efficacy of thickened feeding as treatment for gastroesophageal reflux
81. Thickening of infant feedings for therapy of gastroesophageal reflux
82. Thickened feedings as a cause of increased coughing when used as therapy for gastroesophageal reflux in infants
83. A clinical trial with an "anti-regurgitation" formula
84. Use of a new thickened formula for treatment of symptomatic gastro-oesophageal reflux in infants
85. Clinical response to short-term nasogastric feeding in infants with gastroesophageal reflux and growth failure
86. Effectiveness of positioning therapy for gastroesophageal reflux
87. Seventeen-hour continuous esophageal pH monitoring in the newborn: Evaluation of the influence of position in asymptomatic and symptomatic babies
88. Posture and gastro-oesophageal reflux: A case for left lateral positioning
89. Prone positioning in infant gastroesophageal reflux: Is elevation of the head worth the trouble?
90. The infant seat as treatment for gastroesophageal reflux
91. Body position affects recumbent postprandial reflux
92. Influence of spontaneous sleep positions on nighttime recumbent reflux in patients with gastroesophageal reflux disease
93. Combined effects of sleeping position and prenatal risk factors in sudden infant death syndrome: The Nordic Epidemiological SIDS Study
94. Abandoning prone sleeping: Effect on the risk of sudden infant death syndrome
95. Changes in the epidemiologic profile of sudden infant death syndrome as rates decline California infants: 1990-1995
96. Why the prone position is a risk factor for sudden infant death syndrome
97. Changing concepts of sudden infant death syndrome: Implications for infant sleeping environment sheep position
98. Sheepskin bedding and the sudden infant death syndrome
99. Softness and potential to cause rebreathing: Differences in bedding used by infants at high risk for sudden infant death syndrome
100. Effects of posture on gastro-oesophageal reflux
101. Evaluation of elevation of the head of the bed, bethanechol, and antacid form tablets on gastroesophageal reflux
102. Sleeping on a wedge diminishes exposure of the esophagus to refluxed acid
103. Effects of formula feeding on gastric acidity time and oesophageal pH monitoring data
104. Intravenous fat emulsion (intralipid) delays gastric emptying, but does not cause gastroesophageal reflux in healthy volunteers
105. A comparison of high and low fat meals on postprandial esophageal acid exposure
106. Relationship between postprandial esophageal acid exposure and meal volume and fat content
107. The incidence of gastro-oesophageal reflux after solid and semi-solid meal
108. Effect of increasing the fat content but not the energy load of a meal on gastro-oesophageal reflux and lower oesophageal sphincter motor function
109. Effect of low and high fat meals on lower esophageal sphincter motility and gastro-esophageal reflux in healthy subjects
110. Overweight, but not high dietary fat intake, increases risk of gastroesophageal reflux disease hospitalization: The NHANES 1 Epidemiologic Followup Study
111. Influence of xanthines on gastroesophageal reflux in infants at risk for sudden infant death syndrome
112. The effect of decaffeination of coffee on gastro-oesophageal reflux in patients with reflux disease
113. Effect of decaffeination of coffee or tea on gastro-oesophageal reflux
114. Effect of different coffees on esophageal acid contact time and symptoms in coffee-sensitive subjects
115. The incidence of reflux esophagitis among the Chinese
116. Oesophageal pH-metry: Should meals be standardized?
117. Chocolate and heartburn: Evidence of increased esophageal acid exposure after chocolate ingestion
118. The adverse effect of chocolate on lower esophageal sphincter pressure
119. Oral regurgitation after reflux provoking meals: A possible cause of dental erosion?
120. Symptomatic gastroesophageal reflux: Incidence and precipitating factors
121. The effect of raw onions on acid reflux and reflux symptoms
122. Lack of effect of spearmint on lower oesophageal sphincter function and acid reflux in healthy volunteers
123. Obesity correlates with gastroesophageal reflux
124. Association of obesity with hiatal hernia and esophagitis
125. Weight loss has an independent beneficial effect on symptoms of gastro-oesophageal reflux in patients who are overweight
126. Gastroesophageal reflux in obese patients is not reduced by weight reduction
127. Twenty-four-hour pH measurements in morbid obesity: Effects of massive overweight, weight loss and gastric distension
128. Environmental tobacco smoke exposure and gastroesophageal reflux in infants with apparent life-threatening events
129. The role of "occult" gastroesophageal reflux in chronic pulmonary disease in children
130. Impact of smoking cessation on salivary function in healthy volunteers
131. The effect of cigarette smoking on salivation and esophageal acid clearance
132. Effect of cigarette smoking on the lower oesophageal sphincter
133. Risk factors associated with symptoms of gastroesophageal reflux
134. Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma
135. Effect of cigarette smoking on gastroesophageal reflux measured by 24-h ambulatory esophageal pH monitoring
136. Influence of smoking and esophageal intubation on esophageal pH-metry
137. The immediate effects of cessation of cigarette smoking on gastroesophageal reflux
138. Effect of smoking on the results of esophageal pH measurement in clinical routine
139. Transdermal nicotine and gastroesophageal reflux
140. Environmental tobacco smoke: A hazard to children
141. Passive smoking, sudden infant death syndrome (SIDS) and childhood infections
142. Health effects of passive smoking-10: Summary of effects of parental smoking on the respiratory health of children and implications for research
143. Gastroesophageal reflux in chronic alcoholics. Endoesophageal pH determinations using Heidelberg telemetring capsule
144. The effect of alcohol on nocturnal gastroesophageal reflux
145. Different effects of white and red wine on lower esophageal sphincter pressure and gastroesophageal reflux
146. Low-proof alcoholic beverages and gastroesophageal reflux
147. Effect of ranitidine on twenty-four-hour gastric acidity in infants
148. Use of ranitidine in young infants with gastro-oesophageal reflux
149. Tolerance to intravenous ranitidine
150. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis
151. Ranitidine versus cimetidine in the healing of erosive esophagitis
152. The effect of ranitidine (as effervescent tablets) on the quality of life of GORD patients
153. Famotidine relieves symptoms of gastroesophageal reflux disease and heals erosions and ulcerations. Results of a multicenter, placebo-controlled, dose-ranging study
154. Cimetidine treatment of reflux esophagitis in children: An Italian multicentric study
155. Treatment of childhood peptic esophagitis: A double-blind placebo-controlled trial of nizatidine
156. Do H2 receptor antagonists have a therapeutic role in childhood?
157. Use of the intraesophageal acid perfusion test in provoking nonspecific chest pain in children
158. Ranitidine treatment in pediatry
159. Ranitidine in paediatric patients, a personal experience
160. Acid suppression: Optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome
161. Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: Endoscopic healing and twenty-four-hour intragastric acidity
162. Omeprazole for severe reflux esophagitis in children
163. Omeprazole in infants with cimetidine-resistant peptic esophagitis
164. Histological esophagitis: Clinical and histological response to omeprazole in children
165. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis
166. The medical management of reflux esophagitis. Role of antacids and acid inhibition
167. A comparison of five maintenance therapies for reflux esophagitis
168. Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis
169. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa
170. An evidence-based appraisal of reflux disease management - The Genval workshop report
171. Antacids and cimetidine treatment for gastro-oesophageal reflux and peptic oesophagitis
172. Magnesium hydroxide and aluminum hydroxide in the treatment of gastroesophageal reflux
173. Elevated plasma aluminum levels in normal infants receiving antacids containing aluminum
174. Aluminium absorption and antacid therapy in infancy
175. Aluminum toxicity in childhood
176. Aluminum toxicity in infants and children
177. Metabolic bone disease of total parenteral nutrition
178. Effects of cisapride on parameters of oesophageal motility and on the prolonged intraoesophageal pH test in infants with gastro-oesophageal reflux disease
179. Cisapride for gastro-oesophageal reflux and peptic oesophagitis
180. Cisapride decreases prolonged episodes of reflux in infants
181. Effect of cisapride on gastroesophageal reflux in children with chronic bronchopulmonary disease: A double-blind cross-over pH-monitoring study
182. Cisapride in pediatric gastroesophageal reflux
183. Cisapride in the control of symptoms in infants with gastroesophageal reflux: A randomized, double-blind, placebo-controlled trial
184. Effect of cisapride on excessive regurgitation in infants
185. Esophageal pH assessment of gastroesophageal reflux in 18 patients and the effect of two prokinetic agents: Cisapride and metoclopramide
186. Lack of effect of metoclopramide and domperidone on esophageal peristalsis and esophageal acid clearance in reflux esophagitis. A randomized, double-blind study
187. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease
188. Use of metoclopramide for the treatment of gastroesophageal reflux in infants and children
189. Domperidone drops in the symptomatic treatment of chronic paediatric vomiting and regurgitation. A comparison with metoclopramide
190. Metoclopramide in gastroesophageal reflux of infancy
191. The triangular test to assess the efficacy of metoclopramide in gastroesophageal reflux
192. Metoclopramide pharmacokinetics and pharmacodynamics in infants with gastroesophageal reflux
193. Randomized, prospective double-blind trial of metoclopramide and placebo for gastroesophageal reflux in infants
194. Dose-response study of metoclopramide in gastroesophageal reflux in infancy
195. Tardive dyskinesia associated with use of metoclopramide in a child
196. Use of bethanechol for the treatment of gastroesophageal reflux
197. Bethanechol versus antiacids in the treatment of gastroesophageal reflux
198. Efficacy of domperidone in infants and children with gastroesophageal reflux
199. Domperidone plus magnesium hydroxide and aluminum hydroxide: A valid therapy in children with gastroesophageal reflux. A double-blind randomized study versus placebo
200. The use of cisapride in children
201. Randomized, multicentre comparison of sodium alginate and cisapride in the symptomatic treatment of uncomplicated gastro-oesophageal reflux
202. Gaviscon and Carobel compared with cisapride in gastro-oesophageal reflux
203. Double-blind controlled study on the efficacy of sodium alginate (Gaviscon) in reducing gastroesophageal reflux assessed by 24 h continuous pH monitoring in infants and children
204. The effects of gaviscon and metoclopramide in gastroesophageal reflux in children
205. Sucralfate gel versus placebo in patients with non-erosive gastro-oesophageal reflux disease
206. Sucralfate versus cimetidine in the treatment of reflux esophagitis in children
207. Reoperation after Nissen fundoplication in children with gastroesophageal reflux: Experience with 130 patients
208. Trends in the use of fundoplication in children with gastro-oesophageal reflux
209. Experience with the Nissen fundoplication for correction of gastroesophageal reflux in infants
210. Results and complications of Toupet partial posterior wrap: 10 Years' experience
211. Antireflux surgery in children suffering from reflux-associated respiratory diseases
212. Function of pediatric Nissen-Rossetti fundoplication followed up into adolescence and adulthood
213. Long-term radiographic follow-up of the Nissen fundoplication in children
214. Efficacy of anterior gastric fundoplication in the treatment of gastroesophageal reflux in infants and children
215. The failed antireflux procedure: Analysis of risk factors and morbidity
216. Surgical treatment of gastroesophageal reflux in children: A combined hospital study of 7467 patients
217. Antireflux surgery in children under 3 months of age
218. Toupet fundoplication for gastroesophageal reflux in childhood
219. Fundoplication in children: Experience with 106 cases
220. Dumping syndrome following Nissen fundoplication, diagnosis, and treatment
221. Nutritional management of dumping syndrome associated with antireflux surgery
222. Functional results of laparoscopic fundoplication in children
223. Experience with 220 consecutive laparoscopic Nissen fundoplications in infants and children
224. Surgery for gastroesophageal reflux in children with normal pH studies
225. Increased carrying reduces infant crying: A randomized controlled trial
226. The sleep patterns of normal children
227. The symptom index. Differential usefulness in suspected acid-related complaints of heartburn and chest pain
228. The symptom index: A clinically important parameter of ambulatory 24-hour esophageal pH monitoring
229. Role of gastro-oesophageal reflux in infant irritability
230. The sleep patterns of infants and young children with gastro- oesophageal reflux
231. Esophagitis as a cause of infant colic
232. The crying of infants with colic: A controlled empirical description
233. A practical approach to heartburn
234. Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis
235. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice
236. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease
237. Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux disease
238. A double-blind, placebo-controlled study of the efficacy and safety of non-prescription ranitidine 75 mg in the prevention of meal-induced heartburn
239. Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis
240. The role of gastroesophageal reflux in pediatric dysphagia
241. Clinical and radiologic evaluation reveals high prevalence of abnormalities in young adults with dysphagia
242. Feeding resistance and gastroesophageal reflux in infancy
243. Gastroesophageal reflux in children. Clinical profile, course and outcome with active therapy in 126 cases
244. Feeding problems in infants with gastro-oesophageal reflux disease: A controlled study
245. Feeding disorders in infants and children
246. Outcome of idiopathic apparent life-threatening events: Infant and mother perspectives
247. Clinical characteristics of an apparent life-threatening event (ALTE) and the subsequent occurrence of prolonged apnea or prolonged bradycardia
248. Frequency and timing of recurrent events in infants using home cardiorespiratory monitors
249. Infant apnea: Polygraphic studies and follow-up monitoring
250. Sudden deaths and apparent life-threatening events in hospitalized neonates presumed to be healthy
251. Polysomnographic studies of infants who subsequently died of sudden infant death syndrome
252. Pneumograms in infants who subsequently died of sudden infant death syndrome
253. Care of infants with nearmiss sudden infant death syndrome
254. Identification of a high-risk group for sudden infant death syndrome among infants who were resuscitated for sleep apnea
255. The sudden infant death syndrome and apnea/obstruction during neonatal sleep and feeding
256. Esophagitis and modified Bernstein tests in infants with apparent life- threatening events
257. Patterns of gastroesophageal reflux (GER) in patients with apparent life-threatening events
258. Gastroesophageal reflux in infants with a history of near-miss sudden infant death
259. Gastroesophageal reflux causing respiratory distress and apnea in newborn infants
260. Respiratory arrest in infants secondary to gastroesophageal reflux
261. Gastroesophageal reflux in the "near miss" sudden infant death syndrome
262. Apnea associated with regurgitation in infants
263. Gastroesophageal reflux associated with respiratory abnormalities during sleep
264. Evaluation and management of infantile apnea
265. Lack of temporal relation between acid reflux in the proximal oesophagus and cardiorespiratory events in sleeping infants
266. Observations on gastro-oesophageal reflux, central apnoea and heart rate in infants
267. Gastro-oesophageal reflux and apnoeic pauses during sleep in infancy- no direct relation
268. Gastroesophageal reflux in infants: Relation to apnea
269. Bradycardia and gastroesophageal reflux in term and preterm infants: Is there any relation?
270. Awake apnea associated with gastroesophageal reflux: A specific clinical syndrome
271. The risk of sudden infant death from gastroesophageal reflux
272. Suffocation, recurrent apnea, and sudden infant death
273. A critical review of the studies of the effects of simulated or real gastroesophageal reflux on pulmonary function in asthmatic adults
274. Mechanisms for the association of gastroesophageal reflux and bronchospasm
275. Pathophysiology and mechanisms of gastroesophageal reflux in childhood asthma
276. Intraesophageal perfusion of acid increases the bronchomotor response to methacholine and to isocapnic hyperventilation in asthmatic subjects
277. Gastroesophageal reflux and pulmonary disease
278. Lung function in infants with wheezing and gastroesophageal reflux
279. Lack of significant proximal esophageal acid reflux in infants presenting with respiratory symptoms
280. Diagnosis and treatment of gastroesophageal reflux in 500 children with respiratory symptoms: The value of pH monitoring
281. Bronchial asthma and acid reflux into the distal and proximal oesophagus
282. Gastro-oesophageal reflux and childhood asthma: The acid test
283. The relationship of gastroesophageal reflux to nocturnal wheezing in children with asthma
284. Gastroesophageal reflux-associated recurrent pneumonia and chronic asthma in children
285. Gastroesophageal reflux in steroid-dependent asthmatic youths
286. Recurrent pulmonary disease in children: A complication of gastroesophageal reflux
287. Persistent wheezing and gastroesophageal reflux in infants
288. A trial of ranitidine in asthmatic children and adolescents with or without pathological gastro-oesophageal reflux
289. Asthma and gastroesophageal reflux: Acid suppressive therapy improves asthma outcome
290. Nocturnal asthma: Role of nocturnal gastroesophageal reflux
291. Laparoscopic fundoplication to enhance pulmonary function in children with severe reactive airway disease and gastroesophageal reflux disease
292. Gastroesophageal fundoplication for the management of chronic pulmonary disease in children
293. The effects of antireflux surgery on asthmatics with gastroesophageal reflux
294. Pulmonary infections in children with a partial thoracic stomach ('hiatus hernia')
295. Gastroesophageal reflux in children with chronic recurrent bronchopulmonary infection
296. Pulmonary fibrosis associated with tracheobronchial aspiration. A study of the frequency of hiatal hernia and gastroesophageal reflux in interstitial pulmonary fibrosis of obscure etiology
297. Diagnosing the cause of recurrent and persistent pneumonia in children
298. A comparison of medical and surgical treatment of gastroesophageal reflux in severely retarded children
299. Association of lipid-laden alveolar macrophages and gastroesophageal reflux in children
300. The significance of fat-filled macrophages in the diagnosis of aspiration associated with gastro-oesophageal reflux
301. Recurrent aspiration in children: Lipid-laden alveolar macrophage quantitation
302. Lipid-laden alveolar macrophages (LLAM): A useful marker of silent aspiration in children
303. Chronic aspiration in children: Evaluation of the lipid-laden macrophage index
304. Lipid-laden macrophages in bronchoalveolar lavage fluid as a marker for pulmonary aspiration
305. Respiratory tract infections due to direct and reflux aspiration in children with severe neurodisability
306. Assessment of risk factors for pneumonia in dysphagic children: Significance of videofluoroscopic swallowing evaluation
307. Silent aspiration prominent in children with dysphagia
308. FEESST: A new bedside endoscopic test of the motor and sensory components of swallowing
309. Pediatric laryngopharyngeal sensory testing during FEES: Feasible and Correlative
310. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): A clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury
311. Chronic cough and gastroesophageal reflux
312. Chronic persistent cough and gastro-oesophageal reflux
313. Association of esophageal reflux and globus symptom: Comparison of laryngoscopy and 24-hour pH manometry
314. A prospective study of acid reflux and globus pharyngeus using a modified symptom index
315. Gastroesophageal reflux and posterior laryngitis
316. Laryngeal manifestations of gastroesophageal reflux before and after treatment with omeprazole
317. Proximal esophageal pH-metry in patients with 'reflux laryngitis'
318. Esophagopharyngeal distribution of refluxed gastric acid in patients with reflux laryngitis
319. Gastropharyngeal reflux in infants and children. A pharyngeal pH monitoring study
320. Hoarseness and gastroesophageal reflux in children
321. Irritable oesophagus syndrome as cause of chronic cough
322. Gastroesophageal reflux: A critical factor in pediatric subglottic stenosis
323. Omeprazole for the treatment of posterior laryngitis
324. Outcomes of antireflux therapy for the treatment of chronic laryngitis
325. Hoarseness in a child with gastroesophageal reflux
326. Proximal pH-metry for diagnosis of upper airway complications of gastroesophageal reflux
327. Gastro-oesophageal reflux related cough and its response to laparoscopic fundoplication
328. The prevalence of tooth wear in a cluster sample of adolescent schoolchildren and its relationship with potential explanatory factors
329. Gastroesophageal reflux in children and its relationship to erosion of primary and permanent teeth
330. Outcome of reflux therapy on pediatric chronic sinusitis
331. Nasopharyngeal pH monitoring in infants and children with chronic rhinopharyngitis
332. Otalgia in infants and children-a manifestation of gastroesophageal reflux